Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
san francisco blog main
black diamond therapeutics
boston blog main
boston top stories
cancer
eli lilly
europe blog main
fda
glaxosmithkline
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
abbvie
acceleron pharma
acid sphingomyelinase deficiency
acute migrane
allergan
alzheimer's disease
anika therapeutics
annovis bio
arcutis biotherapeutics
bain capital
baricitinib
bausch health
beam therapeutics
bill & melinda gates foundation
biofourmis
biointellisense
biotechnology industry organization
bladder cancer
blueprint medicines
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
What
companies
3
×
leading
3
×
biotech
black
diamond
drug
ipo
therapeutics
activity
bio
cancer
clinic
continue
days
debut
diamond’s
dog
eluded
firm
hasn’t
hopes
indication
ipos
lead
life
line
lines
mammoth
march
medicines
migraine
molecular
moves
nears
new
ohana’s
pfizer
phase
place
pop
Language
unset
Current search:
xconomy.com
×
companies
×
leading
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs